SENS is a medical tech company focused on the design and development of glucose monitoring products designed to help people with diabetes. Pricetarget wave 2 correction: $3.00 Pricetarget wave 3: $12-24. The pricetarget of wave 3 will likely be driven by the US FDA approval coming march 2021. Hype will most likely drive the early stages of wave 3. Hopefully...
SENS still has some room to run. The price targets are based off of the extended support and resistances of the run up to previous all time highs. Pull backs within the up trend can be expected to retrace to underlying lines drawn when price moves above.
Hello dear padawans of the charts. It looks like SENS broke out of the pennant pre market. You can monitor the price from here for a re-test of the pennant resistance as support or for a drop back within the pennant. If the top of the pennant becomes support we could start rallying again after this brief accumulation within the pennant (the price could also...
We are setting up for a massive breakout. Disregard the people on this website and also on stocktwits attempting to shake you off this multi-multi-bagger. You won't get a chance like this for at least the next ten years. Stay Long and Strong. If you are short this stock, you deserve to feel pain. How can you short a company trying to better our society? Shame on...
$SENS is finally breaking to the upside after putting in multiple bottoms at the $.80 to $.90 level. Yesterday, $SENS put out news that we believe will continue to push the stock higher. As always, trade with caution and use protective stops. Good luck to all! --Cigna coverage decision adds more than 17 million covered lives for Eversense CGM-- GERMANTOWN,...
SENS has been tightening up since late September as you can see on the daily chart. Bull scenario: A closing daily price above $3.21 would be very bullish, and the next resistance points being 3.33, 3.41, and 3.81. These could also be used for rough profit targets. Bear scenario: A closing daily price of 2.80 or lower would be a bear signal, and would likely...